If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 729.00
Bid: 731.00
Ask: 734.00
Change: -9.00 (-1.22%)
Spread: 3.00 (0.41%)
Open: 736.00
High: 740.00
Low: 729.00
Prev. Close: 738.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Group Chief Executive Appointment

18 Oct 2023 07:00

RNS Number : 4425Q
Bodycote PLC
18 October 2023

www.bodycote.com

18 October 2023

THIS ANNOUNCEMENT IS MADE PURSUANT TO PARAGRAPH 9.6.11R OF THE LISTING RULES AND CONTAINS INSIDE INFORMATION

Bodycote plc

Group Chief Executive Appointment

Bodycote plc ("the Company"), the world's leading provider of heat treatment and specialist thermal processing services, today announces the appointment of Jim Fairbairn as Group Chief Executive to succeed Stephen Harris on his retirement. Jim is expected to join the Company and the Board in March 2024 and become Group Chief Executive in May 2024 following an orderly transition. Stephen will step down from the Board and retire from the Company at the next Annual General Meeting on 31 May 2024.

Jim, 54, has considerable experience in managing engineering businesses, having worked with John Wood Group, PE-owned Clyde Bergemann, Howden Group and Megger Group in a career spanning over three decades, with substantial experience as a Divisional and then Group CEO.

Jim joins Bodycote from test & measurement specialist Megger Group in Dover, which he joined as Group CEO in 2017. Under his leadership, its revenues have materially grown to £325m, with operating margins expanding significantly. He also meaningfully evolved Megger's strategy and culture over this period. Prior to Megger, he held executive positions with Howden Group in Glasgow from 2009-2017, concluding his time there as President of the Howden Power, Environment and Process business with global product and service revenues of over $1 billion with 19 sites worldwide.

During his time in Glasgow, Jim chaired the Glasgow Employer Coalition, helping long-term unemployed into work, for which he was awarded an OBE in 2007. Jim has a degree in Mechanical Engineering from the University of Strathclyde, is a Chartered Engineer, a Fellow of the Royal Academy of Engineering and has an honorary Doctor of Science from City University.

Chair of Bodycote, Daniel Dayan, said:

"The Board is delighted to appoint Jim as Bodycote's next Group Chief Executive. His track record in leading and developing specialist global industrial businesses and teams is outstanding and will enable him to contribute rapidly. His understanding of many of our processes, many of our customers, and the nature of our highly varied markets will be of enormous value. I look forward to working with Jim to drive the continuing development and growth of Bodycote."

Group Chief Executive, Stephen Harris said:

"I am confident Jim has the right skills and experience to continue to drive the Company's strategy and performance over the coming years. In the meantime, I remain focused on the initiatives we have in place to develop and solidify Bodycote's leadership position in its chosen markets."

Jim is currently a member of the Dover Harbour Board and expects to have resigned from that position before starting with Bodycote. There are no other details to disclose relating to Jim Fairbairn under paragraph 9.6.13R of the Listing Rules.

About Bodycote

With more than 165 accredited facilities in 22 countries, Bodycote is the world's largest provider of thermal processing services. Through Specialist Technologies and classical heat treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including aerospace, defence, automotive, power generation, medical, oil & gas, construction, and transportation. Customers in all of these industries have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com.

Disclosure

This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU, which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR"). Upon the publication of this announcement, this inside information (as defined in UK MAR) is now considered to be in the public domain. The General Counsel of Bodycote is the person responsible for making this disclosure.

For further information, please contact:

Bodycote plc

Daniel Dayan, Chair

Tel: +44 1625 505 300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOADDLFFXBLZFBF
Date   Source Headline
22nd Jan 20247:00 amRNSAcquisition Update and Share Buyback Programme
8th Jan 20244:37 pmPRNHolding(s) in Company
29th Dec 202312:25 pmPRNTotal Voting Rights
8th Dec 20234:40 pmPRNDirector/PDMR Shareholding
30th Nov 20234:30 pmPRNTotal Voting Rights
22nd Nov 20237:00 amRNSTrading Update
10th Nov 202312:08 pmPRNDirector/PDMR Shareholding
9th Nov 20237:00 amRNSDirector Declaration
31st Oct 20234:30 pmPRNTotal Voting Rights
31st Oct 202310:07 amPRNDirector/PDMR Shareholding
18th Oct 20237:00 amRNSGroup Chief Executive Appointment
9th Oct 20237:00 amRNSSpecialist Tech Acquisitions & New HIP Facility
29th Sep 20234:30 pmPRNBodycote plc - Total Voting Rights
31st Aug 20234:30 pmPRNBodycote plc - Total Voting Rights
16th Aug 20232:38 pmPRNDirector/PDMR Shareholding
4th Aug 202310:43 amPRNHolding(s) in Company
31st Jul 20235:00 pmPRNTotal Voting Rights
27th Jul 20237:00 amRNSInterim results for the six months to 30 June 2023
30th Jun 20235:00 pmPRNTotal Voting Rights
31st May 202312:45 pmRNSSenior Independent Director succession
31st May 202312:43 pmRNSResult of AGM
31st May 20237:00 amRNSGroup Chief Executive Succession Process
31st May 20237:00 amRNSTrading Update
28th Apr 20235:02 pmPRNTotal Voting Rights
17th Mar 20237:00 amRNSFull year results for year ended 31 December 2022
16th Mar 20237:00 amRNSRemuneration Committee Chair Succession
18th Nov 20227:00 amRNSTrading Update
31st Oct 20227:00 amRNSAppointment of Chief Financial Officer
29th Jul 20227:00 amRNSInterim results for the six months to 30 June 2022
28th Jun 20229:22 amRNSHolding(s) in Company
31st May 20225:02 pmPRNTotal Voting Rights
27th May 20224:47 pmRNSHolding(s) in Company
27th May 20227:00 amRNSHolding(s) in Company
26th May 20225:11 pmRNSHolding(s) in Company
25th May 20222:41 pmPRNDirector/PDMR Shareholding
25th May 202212:21 pmRNSResult of AGM
25th May 20227:11 amRNSAudit Committee Chair Succession
25th May 20227:00 amRNSTrading Update
13th Apr 202211:00 amPRNHolding(s) in Company
6th Apr 20229:07 amPRNDirector/PDMR Shareholding
4th Apr 20224:16 pmPRNFinal Dividend Payment Date
31st Mar 20225:02 pmPRNTotal Voting Rights
28th Mar 202212:13 pmPRNDirector/PDMR Shareholding
25th Mar 20223:18 pmPRNDirector/PDMR Shareholding
25th Mar 20221:39 pmPRNAnnual Financial Report
25th Mar 20221:12 pmPRNDirector/PDMR Shareholding
15th Mar 20224:53 pmPRNDirector/PDMR Shareholding
14th Mar 20227:00 amRNSFull year results for year ended 31 December 2021
11th Mar 20227:00 amRNSAppointment of Non-Executive Director
8th Mar 20227:46 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.